Stay updated on Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Washington as a study location under the Locations section. The page revision was updated to v3.3.3 and the HHS Vulnerability Disclosure entry was removed.
    Difference
    0.2%
    Check dated 2025-12-23T09:00:46.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The update shows Revision: v3.3.2 replacing v3.3.1 with no substantive changes to the study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:46:23.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Footer shows revision updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:51:56.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The page-level notice about government funding and NIH operating status has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:15:05.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    There are no additions or deletions between the two screenshots. The page content and study details appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:25:50.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Core content updated with a government-status notice and a new software version (v3.2.0); older version tag (v3.1.0) removed.
    Difference
    4%
    Check dated 2025-10-05T10:35:04.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.